Nasdaq

?? Today, the Nasdaq Foundation and Commonwealth unveiled the results from our research project ‘Transforming Investor Identity’, revealing how identity forms for beginner investors and an actionable toolkit aimed at providers who want to take action today for inclusive investing. ?? The one-year pilot project with three leading financial technology partner platforms - Ellevest, Public and Stash - provides first-of-its kind research to transform the investing system and make it more inclusive to those who have been historically excluded. ?? Learn from beginner investor experiences and join our journey in transforming the investing system here: https://spr.ly/6048gc5dk

??♀? Performance beauty, your way. ? Evolus is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model, and innovative digital platform. ?? $EOLS, congrats on Jeuveau?’s five-year anniversary, and a successful investor day! #EvolveWithUs

??Genmab President & CEO Jan van de Winkel, Ph.D. reflects on 25 years of Genmab! Genmab is an international biotechnology company creating innovative and differentiated antibody therapeutics to improve the lives of patients. #NasdaqListed

The creation of the Nasdaq Stockholm IPO Pulse expands our data-driven approach to anticipating cycles in IPO activity beyond the borders of the U.S. to another market where Nasdaq plays a central role in the healthy functioning of capital markets. Nasdaq Chief Economist, Phil Mackintosh, explains: https://spr.ly/6045WFpyL #MarketMakers

?? MBX Biosciences, Inc. Their mission? To help people with endocrine and metabolic disorders live fuller, healthier lives. ?? MBX Biosciences is harnessing their Precision Endocrine Peptide? (PEP?) platform with a goal to one day change the standard of care of patients in need. ?? Congrats to $MBX as they become #NasdaqListed!

"To be competitive, Europe must remove the legacy national, legal, and regulatory barriers that prevent companies from accessing capital domestically and investors from allocating efficiently to EU investments."- Roland Chai, President of European Markets, Nasdaq Read more in the Financial Times about how Nasdaq’s presence in the Nordic and Baltic regions is a living blueprint of what a successful Capital Markets Union could look like:

Financial crime is an epidemic that not only undermines our economy but also has deep impacts on families and communities. Nasdaq Verafin's new report and op-ed from Nasdaq Chair and CEO Adena Friedman shed light on the alarming economic toll of financial crime in the United States. Learn more: https://spr.ly/6047WL1Kt

?? Actively managed, quantitative, multifactor. ?? Welcoming the ALPS CoreCommodity Natural Resources ETF, $CCNR, to the #NasdaqListed family! ?? Thanks for celebrating with us at Nasdaq!

Recently, we spoke with Igor Rongel, Head of Investment C6 Bank, to discuss the role of technology and innovation in providing better service for their customers.? ? C6 Bank asks themselves “What will be our clients’ need tomorrow?” when thinking about the firm’s next steps.? ? Watch the full video here to learn more about their technology partnership with Nasdaq:?https://lnkd.in/e7P3zE5b

?? “We believe that our clinical trials are showing not just stepwise, but significant benefit to pancreatic cancer patients, as well as Ewing sarcoma, where the medical need is highly unmet.” ?? Actuate Therapeutics, Inc. President & CEO Daniel Schmitt speaks to the clinical-stage biopharmaceutical company’s work in developing therapies for difficult-to-treat cancers. We're thrilled they're now #NasdaqListed.